Division of Cardiovascular Medicine, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.
The Quantitative Sciences Unit, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.
Int J Cardiol. 2019 May 1;282:7-15. doi: 10.1016/j.ijcard.2018.10.073. Epub 2018 Oct 23.
While >20% of patients presenting to the cardiac catheterization laboratory with angina have no obstructive coronary artery disease (CAD), a majority (77%) have an occult coronary abnormality (endothelial dysfunction, microvascular dysfunction (MVD), and/or a myocardial bridge (MB)). There are little data regarding the ability of noninvasive stress testing to identify these occult abnormalities in patients with angina in the absence of obstructive CAD.
We retrospectively evaluated 155 patients (76.7% women) with angina and no obstructive CAD who underwent stress echocardiography and/or electrocardiography before angiography. We evaluated Duke treadmill score, heart rate recovery (HRR), metabolic equivalents, and blood pressure response. During angiography, patients underwent invasive testing for endothelial dysfunction (decrease in epicardial coronary artery diameter >20% after intracoronary acetylcholine), MVD (index of microcirculatory resistance ≥25), and intravascular ultrasound for the presence of an MB.
Stress echocardiography and electrocardiography were positive in 58 (43.6%) and 57 (36.7%) patients, respectively. Endothelial dysfunction was present in 96 (64%), MVD in 32 (20.6%), and an MB in 83 (53.9%). On multivariable logistic regression, stress echo was not associated with any abnormality, while stress ECG was associated with endothelial dysfunction. An abnormal HRR was associated with endothelial dysfunction and MVD, but not an MB.
Conventional stress testing is insufficient for identifying occult coronary abnormalities that are frequently present in patients with angina in the absence of obstructive CAD. A normal stress test does not rule out a non-obstructive coronary etiology of angina, nor does it negate the need for comprehensive invasive testing.
尽管有 20%以上因心绞痛就诊于心导管实验室的患者不存在阻塞性冠状动脉疾病(CAD),但大多数(77%)患者存在隐匿性冠状动脉异常(内皮功能障碍、微血管功能障碍(MVD)和/或心肌桥(MB))。在不存在阻塞性 CAD 的情况下,关于无创应激试验在心绞痛患者中识别这些隐匿性异常的能力的数据很少。
我们回顾性评估了 155 名(76.7%为女性)因心绞痛且无阻塞性 CAD 而行血管造影前负荷超声心动图和/或心电图检查的患者。我们评估了杜克跑步机评分、心率恢复(HRR)、代谢当量和血压反应。在血管造影期间,对患者进行了内皮功能障碍(经冠状动脉内乙酰胆碱后心外膜冠状动脉直径减少>20%)、MVD(微血管阻力指数≥25)和存在 MB 的血管内超声侵入性检查。
负荷超声心动图和心电图分别在 58 名(43.6%)和 57 名(36.7%)患者中呈阳性。96 名(64%)患者存在内皮功能障碍,32 名(20.6%)患者存在 MVD,83 名(53.9%)患者存在 MB。多变量逻辑回归分析显示,负荷超声心动图与任何异常均无关,而负荷心电图与内皮功能障碍有关。异常的 HRR 与内皮功能障碍和 MVD 有关,但与 MB 无关。
传统的应激试验不足以识别在无阻塞性 CAD 的情况下经常存在于心绞痛患者中的隐匿性冠状动脉异常。正常的应激试验不能排除心绞痛的非阻塞性冠状动脉病因,也不能否定全面的侵入性检查的必要性。